From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery

Jan 23, 2016Nature reviews. Drug discovery

From the Blood-Brain Barrier to the Blood-Brain Interface: New Ways to Deliver Drugs to the Brain and Nervous System

AI simplified

Abstract

Achieving sufficient blood-brain barrier (BBB) penetration remains a significant challenge in developing therapeutics for central nervous system (CNS) disorders.

  • The BBB functions as a complex, dynamic interface that adapts to the CNS's needs.
  • Physiological changes can influence the permeability and function of the BBB.
  • The BBB is associated with various disease processes and may even promote certain conditions.
  • Recent research has identified opportunities for innovative approaches to enhance drug delivery to the CNS.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free